Heart-targeted amelioration of sepsis-induced myocardial dysfunction by microenvironment responsive nitric oxide nanogenerators in situ

Table 2 In vivo NO production assessment

Group	Name	Treatment*
1	Control	Saline
2	LPS	LPS
3	PCM-MSN	PCM-MSN + LPS
4	MSN@LA	MSN@LA + LPS
5	PCM-MSN@LA	PCM-MSN@LA + LPS
6	PCM-MSN@LA + LIFU	PCM-MSN@LA + LPS, with LIFU irradiation

*PCM-MSN, MSN@LA and PCM-MSN@LA were all administrated at a dosage of 1 mg kg⁻¹ for 2 min before LPS injection

ISSN: 1477-3155